The lawsuit was filed by Bettie Jane F., a woman from Texas who was implanted with the G2® Inferior Vena Cava Filter (“IVC Filter”) manufactured by C.R. Bard and Bard Peripheral Vascular, Inc.
C.R. Bard G2® Inferior Vena Cava Filter (“IVC Filter”)
The IVC Filter was surgically implanted in her inferior vena cava for the purpose of preventing blood clot complications. It was implanted on October 25, 2011 at a hospital in Texas.
The G2 IVC Filter has been linked to at least 12 deaths and hundreds of injuries, according to an investigative report by NBC News.
Thousands of lawsuits accuse C.R. Bard of continuing to sell the G2 IVC Filter and similar devices, despite high rates of serious complications. Some studies estimate that up to 40% of G2 IVC Filters will fracture if they are left implanted for more than 5.5 years.
The lawsuit was filed on December 26, 2017 in the U.S. District Court for the District of Arizona — Case No. 2:17-cv-04755-DGC.
It will be centralized with over 4,500 other IVC filter lawsuits that have already been filed against C.R. Bard in a centralized federal Multi-District Litigation (MDL No. 2641) — In Re: Bard IVC Filters Products Liability Litigation.
The plaintiff is represented by Ben C. Martin of The Law Offices of Ben C. Martin in Dallas, Texas. He a trial attorney who serves on the plaintiffs’ steering committee of the Bard IVC Filter MDL.
Editor’s note: For more information about IVC Filter lawsuits and your legal rights, please contact The Law Offices of Ben C. Martin.